Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00876304
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Completed Multiple Dose Safety Study of PF-04802540 in Subjects With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: PF-04802540;   Drug: Placebo

Indicates status has not been verified in more than two years